ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,602.50
-0.80%
S&P ASX All Technology
3,003.00
-0.39%
Brent Oil
85.635
-0.30%
US Dollar vs AUD
1.5444
0.02%
Bitcoin
60,513.98
-0.14%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. SAB Biotherapeutics Inc (SABSW)

  7. SAB Biotherapeutics Inc (SABSW) News

SABSW SAB Biotherapeutics Inc

0.035
0.0046 (15.13%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
SAB Biotherapeutics Inc SABSW NASDAQ Equity Warrant
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
0.0046 15.13% 0.035 09:50:01
Open Price Low Price High Price Close Price Previous Close
0.035 0.035 0.035 0.035 0.0304
more quote information »

Recent News

Date Time Source Heading
16/4/202421:15GLOBESAB Biotherapeutics Provides SAB-142 Trial Update
08/4/202421:15GLOBESAB Biotherapeutics to Present at INNODIA Annual Meeting
04/4/202422:15GLOBESAB Biotherapeutics to Present at the Needham Virtual..
29/3/202422:15GLOBESAB Biotherapeutics Reports Full Year 2023 Operating and..
26/3/202401:15GLOBESAB Biotherapeutics Announces Clinical Partnership with..
24/2/202400:00GLOBESAB Biotherapeutics to Present at the BIO CEO & Investor..
09/2/202400:00GLOBESAB Biotherapeutics to Present at the Oppenheimer..
02/2/202423:30GLOBESAB Biotherapeutics Announces Executive Leadership Change
24/1/202409:58GLOBESAB Biotherapeutics Regains Compliance with Nasdaq Minimum..
03/1/202408:30GLOBESAB Biotherapeutics Announces 1-for-10 Reverse Stock Split
29/11/202323:30GLOBESAB Biotherapeutics Announces Commencement of the HUMAN..
20/11/202323:30GLOBESAB Biotherapeutics Appoints Katie Ellias to the Board of..
14/11/202323:30GLOBESAB Biotherapeutics Announces Completion of $67.1 Million..
14/11/202323:15GLOBESAB Biotherapeutics Announces Q3 2023 Financial Results and..
09/11/202323:30GLOBESAB Biotherapeutics to Present at Piper Sandler Healthcare..
24/10/202322:30GLOBESAB Biotherapeutics Appoints Michael G. King Jr. as Chief..
19/10/202322:30GLOBESAB Biotherapeutics Receives Australian Approval to Commence..
05/10/202322:30GLOBESAB Biotherapeutics Approves Appointment of Andrew Moin to..
02/10/202322:30GLOBESAB Biotherapeutics Announces Private Placement of up to..
21/8/202322:30GLOBESAB Biotherapeutics Provides Company Update for Q2..
21/6/202322:30GLOBESAB Biotherapeutics Presents Positive IND-Enabling GLP..
30/5/202322:30GLOBESAB Biotherapeutics to Present Novel Human IgG Platform with..
19/5/202322:30GLOBESAB Biotherapeutics Presents Virtual 2023 R&D Day Portfolio..
16/5/202322:30GLOBESAB Biotherapeutics Provides Company Update for Q1 2023..
12/5/202322:30GLOBESAB Biotherapeutics Announces First Publication of Promising..
09/5/202322:30GLOBESAB Biotherapeutics Announces Progress on U.S. FDA’s Phased..
04/5/202322:30GLOBESAB Biotherapeutics Presents Positive Phase 1 and 2a Data..
04/5/202307:00GLOBESAB Biotherapeutics to Present at Sidoti Virtual Investor..

Your Recent History

NASDAQ
SABSW
SAB Biotherapeutics
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved